4th Quarter - Report

TIBER CREEK GROUP for AMGEN INC

Firm
Client
Income
$100,000
Expenses
—

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Follow-on biologics. H.R. 1427/S. 726, the Promoting Innovation and Access to Life Saving Medicines Act. H.R.1548, Pathway for Biosimilars Act. S. 1679, Affordable Health Choices Act. S. 1796, Americas Healthy Future Act of 2009.

LobbyistCovered position, as disclosed
JOHN MICHAEL GONZALEZ CoS, Representative Bean
JONATHON JONES —
SHEILA MURPHY LD, Sen. Klobuchar

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: S. 726 (111th), S. 1679 (111th), S. 1796 (111th), H.R. 1427 (111th), H.R. 1548 (111th)

Medicare/Medicaid MMM

Medicare coverage and reimbursement issues.

LobbyistCovered position, as disclosed
JOHN MICHAEL GONZALEZ CoS, Representative Bean
JONATHON JONES —
SHEILA MURPHY LD, Sen. Klobuchar

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.